Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

To Improve Adverse Event Tracking, FDA Could Google It

This article was originally published in The Tan Sheet

Executive Summary

Teleconference between Google and FDA signals the internet search giant could have a way to improve adverse event detection. The agency calls the talk “a high-level, general discussion” of Google’s capabilities.

You may also be interested in...



FDA Acquires Trove Of Rx Safety Data Through Alliance With PatientsLikeMe

Research collaboration will give FDA access to individual drug safety reports from patient network’s 350,000 members and could lead to future projects on post-market surveillance.

Social Media Guidance Gives Drug Firms A Pass On User Content

The draft guidance outlines substantial reporting requirements for websites that firms control and for content on third-party sites – as well as saying when FDA intends to use enforcement discretion.

Social Media Site Could Help FDA Track Adverse Events

FDA-pharma partnership could improve data quality and increase use as industry continues to struggle to incorporate social media into pharmacovigilance.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS107804

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel